Two Sigma Investments’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANRO
Two Sigma Investments's ANRO Position: Q3 2026 in Review
Two Sigma Investments reduced its Alto Neuroscience (ANRO) stake by 31% in Q3 2026, selling an estimated $1.36M and leaving 101,879 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2819.
Two Sigma Investments first reported a position in ANRO in Q3 2024 and has held it in 9 quarters since. The position peaked at $4.86M in Q1 2026. 133 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.
- Two Sigma Investments held 101,879 shares of Alto Neuroscience worth $2.6M as of Q3 2026.
- Two Sigma Investments sold 45,420 Alto Neuroscience shares in Q3 2026, an estimated $1.36M.
- Alto Neuroscience made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #2819 holding.
- Two Sigma Investments first reported a position in Alto Neuroscience in Q3 2024 and has held it in 9 quarters since.
- Two Sigma Investments's Alto Neuroscience position peaked at $4.86M in Q1 2026.
- 133 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.